Previous 10 | Next 10 |
home / stock / vphif / vphif news
Valeo Pharma Obtains Public Reimbursement for Redesca™ and Redesca Hp™ in Quebec Canada NewsWire Public reimbursement coverage reaches 9 Provinces in Canada Canadian private health plan coverage now exceeding 90% MONTREAL , Nov...
Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta Canada NewsWire First provincial public listing secured for both asthma medications Additional provincial public reimbursement cover...
/C O R R E C T I O N from Source -- Valeo Pharma inc./ PR Newswire In the news release, Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada, issued 13-Oct-2021 by Valeo Pharma inc. over CNW, we are advised by the company...
Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada PR Newswire 2 Group Purchasing Organizations (GPO) listing agreements cover, Redesca™ and Redesca HP™, as well as 3 other Valeo hospital products ...
Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Enerzair® Breezhaler® and Atectura® Breezhaler® PR Newswire Agreement to provide framework to participating jurisdictions in support of provincial public listings an...
Valeo Pharma Announces Record Revenues and Gross Margins for its Third Quarter 2021 Canada NewsWire Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over prior quarter. Record gross margin of $2.2 million , up 1602% over ...
Valeo Pharma To Report Third Quarter 2021 Results and Hold Investors Conference Call / Webcast Canada NewsWire MONTREAL , Sept. 16, 2021 /CNW Telbec/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian ...
Valeo Pharma Reports on Launch of New Corporate Structure Canada NewsWire Sales team expands to 65 bringing total employees to 95 National sales structure now actively deployed in support of Enerzair ® Breezhaler ® and Atectura ® Br...
Valeo Pharma Announces Additional Provincial Reimbursement Coverage for Redesca™ and Redesca HP™ Canada NewsWire Redesca™ and Redesca HP™ now covered for public reimbursement in 7 provinces and territories across Canada Priva...
Valeo Pharma (VPHIF): FQ2 GAAP EPS of -C$0.03.Revenue of C$2.65M (+27.4% Y/Y)Press Release For further details see: Valeo Pharma reports FQ2 results
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million rec...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada NewsWire Changes to respiratory business unit to generate more than $5 million in annual savings Follows previously announced cost saving measures exce...